Free shipping on all orders over $ 500

SU4312

Cat. No. M3993

All AbMole products are for research use only, cannot be used for human consumption.

SU4312 Structure
Synonym:

SU-4312; NSC 86429; DMBI

Size Price Availability Quantity
5mg USD 100  USD100 In stock
10mg USD 170  USD170 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

SU4312 unexpectedly prevented MPP(+) -induced neuronal apoptosis in vitro and decreased MPTP-induced loss of dopaminergic neurons, reduced expression of mRNA for tyrosine hydroxylase and impaired swimming behaviour in zebrafish.The neuroprotective actions of SU4312 were independent of its anti-angiogenic action.SU4312 exhibited non-competitive inhibition of purified neuronal NOS (nNOS) with an IC(50) value of 19.0 μM but showed little or no effects on inducible and endothelial NOS.Molecular docking simulations suggested an interaction between SU4312 and the haem group within the active centre of nNOS.

*The compound is unstable in solutions, freshly prepared is recommended

Chemical Information
Molecular Weight 264.32
Formula C17H16N2O
CAS Number 5812-07-7
Form Solid
Solubility (25°C) DMSO 40 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Wei Cui, et al. Br J Pharmacol. The anti-cancer agent SU4312 unexpectedly protects against MPP(+) -induced neurotoxicity via selective and direct inhibition of neuronal NOS

[2] Akiko Miki, et al. J Cell Physiol. Prolonged blockade of VEGF receptors does not damage retinal photoreceptors or ganglion cells

[3] Caroline Schultheiss, et al. Angiogenesis. In vivo characterization of endothelial cell activation in a transgenic mouse model of Alzheimer's disease

Related VEGFR/PDGFR Products
Conbercept

Conbercept (KH902) is a monoclonal antibody targeting VEGFRA fused to the IGHG1 Fc fragment. Conbercept is produced by the fusion of the second C-LIKE of FLT1 and the third and fourth C-LIKE of KDR with IGHG1 Fc.

SU5208 

SU5208 inhibits vascular endothelial growth factor receptor-2 (VEGFR2).

VEGFR-IN-1 

VEGFR-IN-1 is a potent angiogenesis inhibitor with IC50s of 0.02, 0.18, 0.24 7.3, and 7 µM for KDR, Flt-1, c-Kit, EGF-R, and c-Src, respectively.

(Z)-Orantinib

(Z)-Orantinib ((Z)-SU6668) is a potent, selective, orally active and ATP competitive inhibitor of Flk‐1/KDR, PDGFRβ, and FGFR1, with IC50s of 2.1, 0.008, and 1.2 µM, respectively.

(Rac)-SAR131675 

(Rac)-SAR131675 is the racemate of SAR131675.

  Catalog
Abmole Inhibitor Catalog




Keywords: SU4312, SU-4312; NSC 86429; DMBI supplier, VEGFR/PDGFR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.